|
Subsequent Events - Additional Information (Detail) (USD $)
|
1 Months Ended | 1 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
|
May 31, 2011
Series B Preferred Stock
|
Jul. 31, 2012
Credit Facility
Platinum-Montaur Life Sciences, LLC
|
Jul. 31, 2012
Credit Facility
Platinum-Montaur Life Sciences, LLC
Upon FDA approval of Lymphoseek
|
Jul. 31, 2012
Credit Facility
Platinum-Montaur Life Sciences, LLC
Potentially available on terms to be negotiated
|
Jul. 31, 2012
Credit Facility
Platinum-Montaur Life Sciences, LLC
Prime Lending Rate
|
Jul. 31, 2012
Conversion of Stock
Series B Preferred Stock
|
Jul. 31, 2012
Licensing Agreements
|
Jul. 31, 2012
Licensing Agreements
At the time of product registration or upon commercial sales
|
|
| Subsequent Event [Line Items] | ||||||||
| Loan Agreement, maximum borrowing capacity | $ 50,000,000 | $ 20,000,000 | $ 15,000,000 | $ 15,000,000 | ||||
| Debt instrument annual interest rate | 10.00% | |||||||
| Number of shares of convertible preferred stock converted | 917 | 3,063 | ||||||
| Number of common stock issued up on conversion | 2,998,590 | 10,016,010 | ||||||
| One-time sub-license execution payment | 175,000 | |||||||
| One-time sub-license execution payment | 300,000 | |||||||
| Contingent milestone payments | $ 2,900,000 | $ 2,500,000 | ||||||
| Common stock issued, shares | 1,150,000 | 950,000 | ||||||
| X | ||||||||||
|
- Definition
License Agreement Payment No definition available.
|
| X | ||||||||||
|
- Definition
Milestone Payments, Maximum Amount No definition available.
|
| X | ||||||||||
|
- Definition
Milestone Payments, Maximum Shares No definition available.
|
| X | ||||||||||
|
- Definition
The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Interest rate stated in the contractual debt agreement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. No definition available.
|
| X | ||||||||||
|
- Details
|